Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. April 16, 2019. Bakul Patel.

Executive Summary

The US FDA's top digital health officer, Bakul Patel, has been talking to regulators from Canada, Singapore and Japan that are interested in learning more about the agency’s pre-cert pilot program. See what Patel said here.

"There are a lot of people who have been observing what we're doing. [Other regulators] may be still trying to figure out how to translate [the precertification program] into their laws or legal structure, but everybody is very interested. At least that's what's the impression I get." – Bakul Patel, associate director of digital health, US FDA's Center for Devices and Radiological Health

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT124949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel